Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/8571
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOzturk, I. I.en
dc.contributor.authorHadjikakou, S. K.en
dc.contributor.authorHadjiliadis, N.en
dc.contributor.authorKourkoumelis, N.en
dc.contributor.authorKubicki, M.en
dc.contributor.authorTasiopoulos, A. J.en
dc.contributor.authorScleiman, H.en
dc.contributor.authorBarsan, M. M.en
dc.contributor.authorButler, I. S.en
dc.contributor.authorBalzarini, J.en
dc.date.accessioned2015-11-24T16:42:35Z-
dc.date.available2015-11-24T16:42:35Z-
dc.identifier.issn0020-1669-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/8571-
dc.rightsDefault Licence-
dc.subjectmolecular-orbital methodsen
dc.subjectcrystal-structuresen
dc.subjectbasis setsen
dc.subjectdensityen
dc.subjectexchangeen
dc.subjectligandsen
dc.subjectseriesen
dc.titleNew Antimony(III) Bromide Complexes with Thioamides: Synthesis, Characterization, and Cytostatic Propertiesen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryDoi 10.1021/Ic8019205-
heal.identifier.secondary<Go to ISI>://000263667700053-
heal.identifier.secondaryhttp://pubs.acs.org/doi/pdfplus/10.1021/ic8019205-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2009-
heal.abstractNew antimony(III) bromide complexes with the heterocyclic thioamides, thiourea (TU), 2-mercapto-1-methylimidazole (MMI), 2-mercapto-benzimidazole (MBZIM), 2-mercapto-5-methyl-benzimidazole (MMBZIM), 5-ethoxy-2-mercapto-benzimidazole (EtMBZIM), 2-mercapto-3,4,5,6-tetrahydro-pyrimidine (tHPMT), 2-mercaptopyridine (PYT), 2-mercapto-thiazolidine (MTZD), 3-methyl-2-mercaptobenzothiazole (MMBZT), and 2-mercaptopyrimidine (PMTH) of formulas [SbBr(3)(TU)(2)] (1), [SbBr(3)(MMI)(2)] (2), {[SbBr(2)(MBZIM)(4)](+) [Br](-) H(2)O} (3), {[SbBr(2)(mu(2)-Br)(MMBZIM)(2)](2)} (4), {[SbBr(2)(mu(2)-Br)(EtMBZIM)(2)](2) MeOH} (5), {[SbBr(3)(mu(2)- S-tHPMT)(tHPMT)](n)} (6), ([SbBr(2)(mu(2)-Br)(PYT)(2))(n)} (7), {[SbBr(2)(mu(2)-Br)(MTZD)(2)](n)} (8), [SbBr(3)(MMBZT)(2)] (9), and {[SbBr(5)](2-) [(PMTH(2)(+))(2)]} (10) have been synthesized and characterized by elemental analysis, conductivity measurements, FTIR spectroscopy, FT-Raman spectroscopy, TG-DTA analysis, and X-ray powder diffraction. The crystal structures of 3, 4, 5, 6, 7, 8, and 10 were also determined by X-ray diffraction. In 3, four sulfur atoms from thione ligands and two bromide ions form an octahedral (O(h)) cationic [SbS(4)Br(2)](+) species in which the two bromide anions lie at axial positions. A third bromide counteranion neutralizes the whole complex. 4 and 5 are dimers, whereas 6, 7 and 8 are polymers, built up by monomeric units of square pyramidal (SP) geometry around the metal center, which were formed by two sulfur atoms of thioamide ligands and three bromide ions. Finally, 10 is ionic salt containing 1D polymeric network of {[SbBr(5)](2-)}(n) anions and -[(PMTH(2)(+))(2)] counter cations. in the lattice. The complexes showed mostly a moderate cytostatic activity against a variety of tumor cell lines.en
heal.publisherAmerican Chemical Societyen
heal.journalNameInorg Chemen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Ozturk-2009-New Antimony(III) Br.pdf383.51 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons